UNC Health Medication Formulary
Add Formweb to your mobile device
UNC Health Medication Formulary
System Formulary Update
Amivantamab-vmjw (Rybrevant)
Situation
Amivantamab-vmjw (Rybrevant) 350 mg/7 mL (50 mg/mL) SDV for injection was approved for addition to the health system formulary at the November 2022 System Pharmacy and Therapeutics Committee meeting.
Background
The following medication was reviewed: Amivantamab-vmjw (Rybrevant) 350 mg/7 mL (50 mg/mL) SDV for injection
Assessment/Recommendations
System P&T voted to include the following products on the UNC Health System Drug Formulary:
- Amivantamab-vmjw (Rybrevant) 350 mg/7 mL (50 mg/mL) SDV for injection
Note: Stock of this formulary product may vary at individual entities
Formulary/Epic changes will Go-Live on Tuesday, February 28, 2023.